UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059611 |
|---|---|
| Receipt number | R000068192 |
| Scientific Title | MASCC International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis |
| Date of disclosure of the study information | 2025/11/01 |
| Last modified on | 2025/11/01 00:13:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
MASCC International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis
Acronym
MASCC International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis
Scientific Title
MASCC International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis
Scientific Title:Acronym
MASCC International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis
Region
| Japan | Asia(except Japan) | North America |
| South America | Australia | Europe |
| Africa |
Condition
Condition
Breast Cancer-Related Lymphoedema (BCRAL)
Classification by specialty
| Breast surgery | Plastic surgery | Laboratory medicine |
| Operative medicine | Rehabilitation medicine | Nursing |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
1. Capture the current BCRAL diagnostic methods, interventions and prospective surveillance programs in each area, country and every continent around the world
2. Understand the barriers, facilitators and needs for early BCRAL diagnosis and interventions in the real world.
Basic objectives2
Others
Basic objectives -Others
1. Capture the current BCRAL diagnostic methods, interventions and prospective surveillance programs in each area, country and every continent around the world
2. Understand the barriers, facilitators and needs for early BCRAL diagnosis and interventions in the real world.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Key differences in diagnostic and intervention practices and the barriers to implementing effective BCRAL care
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The participants must be current BCRAL health providers including medical doctors, nurses, nurse practitioner (NP), massage therapists, occupational therapists, physician assistants (PA), physical therapists / physiotherapists (PT), any licensed healthcare practitioner who cares for people with or at risk of developing BCRAL from the various disciplines. We will endeavor to obtain responses from at least 5 participants from each continent including low- and middle-income countries. The participants must have signed and dated an IRB-approved consent form online that conforms to federal and institutional guidelines.
Key exclusion criteria
Past lymphoedema health providers (Not involved in patients care at the time of survey)
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Kaori |
| Middle name | |
| Last name | Tane |
Organization
Hyogo Cancer Center, Kobe University Graduate School of Medicine
Division name
Breast Surgery
Zip code
673-8558
Address
13-70, Kitaojicho, Akashi, Hyogo, Japan
TEL
078-929-1151
kfukudaygc@gmail.com
Public contact
Name of contact person
| 1st name | Kaori |
| Middle name | |
| Last name | Tane |
Organization
Hyogo Cancer Center
Division name
Breast Surgery
Zip code
673-8558
Address
13-70, Kitaojicho, Akashi, Hyogo, Japan
TEL
078-929-1151
Homepage URL
kfukudaygc@gmail.com
Sponsor or person
Institute
Kaori Tane, Breast Surgery, Hyogo Cancer Center, Japan
Institute
Department
Personal name
Funding Source
Organization
Nothing
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Human Research Ethics Committee, yogo Cancer Center, Japan
Address
13-70, Kitaojicho, Akashi, Hyogo, Japan
Tel
078-929-1151
kfukudaygc@gmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 10 | Month | 10 | Day |
Date of IRB
| 2025 | Year | 10 | Month | 20 | Day |
Anticipated trial start date
| 2025 | Year | 10 | Month | 20 | Day |
Last follow-up date
| 2026 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
International Healthcare Professional Survey of Current Practices of Managing Breast Cancer-Related Lymphoedema and Lymphoedema-Related Cellulitis
Management information
Registered date
| 2025 | Year | 11 | Month | 01 | Day |
Last modified on
| 2025 | Year | 11 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068192
